首站-论文投稿智能助手
典型文献
Clinical practice of rapid antigen tests for SARS-CoV-2 Omicron variant:A single-center study in China
文献摘要:
Responding to the fast-spreading SARS-CoV-2 Omicron variant,to improve screening efficiency,rapid antigen tests(RATs)were first added as a supplementary detection method in China in mid-March,2022.What and how big a role RATs should play need to be supported by clinical data.Here,RAT performance and relevant factors in comparison with nucleic acid amplification tests(NAATs)were assessed in Omicron-infected inpatients.From the NAAT results,nasopharyngeal swabs(NPs)performed better than oropharyngeal swabs(OPs).RATs tested on NAAT positive NPs performed better than those with OP-positive samples.The RAT positivity rate was strongly associated with high levels of N and OFR1ab genes,especially in NPs where patients also had significantly longer hospital stays and shorter days from symptom onset to RAT testing.Self-performed RATs had a detection accuracy that was comparable to professionally performed RATs when the subjects were well guided.The antigen negative rate of the studied patients was 100%at discharge.These findings suggest that,in addition to a supplementary detection role,RATs can be an important strategy for evaluating the disease progression of Omicron-infected inpatients.This study provides important clinical data to support better rules regarding RATs under China's CO VID-19 prevention and control policy.
文献关键词:
作者姓名:
Mengyuan Chen;Jiaqin Xu;Lingjun Ying;Miaoguo Cai;Tao-Hsin Tung;Kai Zhou;Yufen Zheng;Xiaojie Bi;Jing Wang;Xi Tu;Bo Shen;Dongqing Lv
作者机构:
Department of Laboratory Medicine,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China;Hepatology and Infectious Diseases Center,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China;Department of Radiation Oncology,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China;Evidence-based Medicine Center,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China;Department of Respiratory and Critical Diseases,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China
文献出处:
引用格式:
[1]Mengyuan Chen;Jiaqin Xu;Lingjun Ying;Miaoguo Cai;Tao-Hsin Tung;Kai Zhou;Yufen Zheng;Xiaojie Bi;Jing Wang;Xi Tu;Bo Shen;Dongqing Lv-.Clinical practice of rapid antigen tests for SARS-CoV-2 Omicron variant:A single-center study in China)[J].中国病毒学,2022(06):842-849
A类:
Responding,OFR1ab
B类:
Clinical,practice,rapid,antigen,tests,SARS,CoV,Omicron,variant,single,center,study,China,fast,spreading,improve,screening,efficiency,RATs,were,first,added,supplementary,detection,method,mid,March,What,how,big,role,should,play,need,supported,by,clinical,data,Here,performance,relevant,factors,comparison,nucleic,acid,amplification,NAATs,assessed,infected,inpatients,From,results,nasopharyngeal,swabs,NPs,performed,better,than,oropharyngeal,OPs,tested,positive,those,samples,positivity,was,strongly,associated,high,levels,genes,especially,where,also,had,significantly,longer,hospital,stays,shorter,days,from,symptom,onset,testing,Self,accuracy,that,comparable,professionally,when,subjects,well,guided,negative,studied,discharge,These,findings,suggest,addition,important,strategy,evaluating,disease,progression,This,provides,rules,regarding,under,VID,prevention,control,policy
AB值:
0.561879
相似文献
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China
Wei Yumei;Juan Juan;Su Rina;Song Geng;Chen Xu;Shan Ruiqin;Li Ying;Cui Shihong;Fan Shangrong;Feng Ling;You Zishan;Meng Haixia;Cai Yan;Zhang Cuilin;Yang Huixia-Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China;Department of Obstetrics, Tianjin Central Obstetrics and Gynecology Hospital, Tianjin 300199, China;Department of Obstetrics, Jinan Maternal and Child Health Hospital, Jinan, Shandong 250000, China;Department of Obstetrics, Dalian Maternity Hospital, Dalian, Liaoning 116033, China;Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Obstetrics, Shenzhen Peking University Hospital, Shenzhen, Guangdong 518036, China;Department of Obstetrics and Gynecology, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Obstetrics and Gynecology, Suzhou Jiulong Hospital Affiliated to Shanghai Jiaotong University, Suzhou, Jiangsu 320571, China;Department of Obstetrics, Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010050, China;Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20817, USA
Quality metrics and outcomes among critically ill patients in China: results of the national clinical quality control indicators for critical care medicine survey 2015-2019
Rui Xi;Dong Fen;Ma Xudong;Su Longxiang;Shan Guangliang;Guo Yanhong;Long Yun;Liu Dawei;Zhou Xiang-Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100029, China;Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China;Department of Medical Administration, National Health Commission of the People’s Republic of China, Beijing 100044, China;Department of Epidemiology and Biostatistics, Institute of Basic Medicine Sciences, Chinese Academy of Medical Sciences (CAMS) & School of Basic Medicine, Peking Union Medical College, Beijing 100005, China
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Existing tests vs. novel non-invasive assays for detection of invasive aspergillosis in patients with respiratory diseases
Xiao Wei;Du Longyi;Cai Linli;Miao Tiwei;Mao Bing;Wen Fuqiang;Gibson Peter Gerard;Gong Deying;Zeng Yan;Kang Mei;Du Xinmiao;Qu Junyan;Wang Yan;Liu Xuemei;Feng Ruizhi;Fu Juanjuan-Respiratory Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Divison of Pulmonary Diseases, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China;West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041, China;Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW 2305, Australia;Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia;Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW 2305, Australia;Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China;Department of Pneumology, Pidu District of Traditional Chinese Medicine, The Third Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611730, China;Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Center of Infectious Disease, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Research Core Facility, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。